Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


IMS acquires Russian consultancy

This article was originally published in Scrip

Executive Summary

IMS Health, the market intelligence and statistics consultancy, has acquired RMBC, which provides pharmaceutical market intelligence and analytics for the Russian market. RMBC gathers retail and hospital prescribing data from Russia, Ukraine, Belarus, Kazakhstan and Uzbekistan. IMS says that Russia and the Commonwealth of Independent States together represent a pharmaceutical market worth $10 billion that is growing at 10-15% annually.





Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts